| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.015 | 0.8 |